Patents

US 12760034 B2: Rifamycin analogs

Granted
2026-10-13
Filed
2022-01-19 application 18261932
Type
Utility · 28 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are compounds that are potent inhibitors of the Mycobacterium tuberculosis (MTB) RNA polymerase (RNAP), which exhibit significantly reduced activation of the human pregnane X receptor (hPXR), resulting in dramatically reduced C induction of hepatic cytochromes P450 2C9 and 3A4 (CYP2C9, CYP3A4), as well as a number of Phase II metabolism enzymes. Also provided herein are pharmaceutical compositions comprising the compounds, and methods of treating tuberculosis using the compounds.

Source: PTBLXML, file of 2026-10-13 (ipgb20261013.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2,342 patentsUS company or organizationAnn Arbor, MITHE REGENTS OF THE UNIVERSITY OF MICHIGAN CORP. State business registration FUZZY medium confidence: same name (legal endings aside) and statePTBLXML, file of 2026-10-13
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 1,493 patentsUS company or organizationUrbana, ILTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Nonprofit EXACT high confidence: identical full name and statePTBLXML, file of 2026-10-13
THE PENN STATE RESEARCH FOUNDATION 710 patentsUS company or organizationUniversity Park, PAThe Penn State Research Foundation State business registration EXACT high confidence: identical full name and state
PENN STATE RESEARCH FOUNDATION Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PTBLXML, file of 2026-10-13

Inventors

InventorPlacePatentsPerson pageSource
George GarciaAnn Arbor, MIPTBLXML, file of 2026-10-13
Hollis ShowalterAnn Arbor, MIPTBLXML, file of 2026-10-13
Walajapet RajeswaranAnn Arbor, MI3PTBLXML, file of 2026-10-13
Pil LeeAnn Arbor, MIPTBLXML, file of 2026-10-13
Scott FranzblauUrbana, IL2PTBLXML, file of 2026-10-13
Katsuhiko MurakamiUniversity Park, PAPTBLXML, file of 2026-10-13

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D498/18PTBLXML, file of 2026-10-13
A61KPreparations for medical, dental or toiletry purposesA61K31/5386PTBLXML, file of 2026-10-13
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/06PTBLXML, file of 2026-10-13

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.